I Cervenka, M Al Rahmoun, Y Mahamat-Saleh, A Fournier, M C Boutron-Ruault, G Severi, S Caini, D Palli, R Ghiasvand, M B Veierod, E Botteri, A Tjønneland, A Olsen, R T Fortner, R Kaaks, M B Schulze, S Panico, A Trichopoulou, C Dessinioti, K Niforou, S Sieri, R Tumino, C Sacerdote, B Bueno-de-Mesquita, T M Sandanger, S Colorado-Yohar, M J Sánchez, L Gil Majuelo, L Lujan-Barroso, E Ardanaz, S Merino, K Isaksson, S Butt, I Ljuslinder, M Jansson, R C Travis, K T Khaw, E Weiderpass, L Dossus, S Rinaldi, M Kvaskoff
Evidence suggests an influence of sex hormones on cutaneous melanoma risk, but epidemiologic findings are conflicting. We examined the associations between use of oral contraceptives (OCs) and menopausal hormone therapy (MHT) and melanoma risk in women participating in the European Prospective Investigation into Cancer and Nutrition (EPIC). EPIC is a prospective cohort study initiated in 1992 in 10 European countries. Information on exogenous hormone use at baseline was derived from country-specific self-administered questionnaires...
September 10, 2019: International Journal of Cancer. Journal International du Cancer